Lorlatinib Versus Crizotinib in Patients With Advanced
            <i>ALK</i>
            -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study

v1

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/835B6182.svg?ark=w1%2F20260526%2F835B6182)](https://nobleid.org/work/w1/20260526/835B6182)

Authors & Claims

Paper Authors